APRN Pharmacology Today: Treatment Of Major Depressive Disorders And Resistant Depression
Katie S. Adams
Register now for this online course and take the first steps toward safe prescribing practices.
Due to the widespread nature of depression, seasoned APRNs are likely to interact with patients dealing with depression or those taking antidepressant medications on a daily basis. In this new APRN Pharmacology Today online course, you will review pharmacotherapeutic options for the treatment of major depressive disorder (MDD), current clinical practice guideline recommendations for treatment of depression, and strategies to address treatment-resistant depression.
It’s time to have a better understanding of patients with depression. Join Katie S. Adams, Pharm.D., BCPP, BCPS, clinical pharmacy specialist in behavioral health at St. Mary’s Hospital in Richmond, Virginia, for this new self-paced online course.
This innovative pharmacology module includes case studies, self-assessment quizzes, and reflection to engage learners and illustrate drug contexts for major depressive disorder, along with information on available drug treatments for depression, current clinical practice guidelines, standards of care, and therapeutic options for patients whose first-line treatments fail. Register now for this online course and take the first steps toward safe prescribing practices.
Key Learning Outcomes
After taking this interactive online course, you will be able to:
- Describe diagnostic criteria for major depressive disorder (MDD), and characterize treatment-resistant depression.
- Review current literature and guideline recommendations for the treatment of MDD.
- Compare and contrast the available pharmacologic treatments for MDD
- Formulate a treatment and monitoring plan for a patient with MDD.